Opaleye Management as of March 31, 2018
Portfolio Holdings for Opaleye Management
Opaleye Management holds 38 positions in its portfolio as reported in the March 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Axogen (AXGN) | 17.9 | $63M | 1.7M | 36.50 | |
Blueprint Medicines (BPMC) | 15.7 | $55M | 600k | 91.70 | |
Loxo Oncology | 5.9 | $21M | 179k | 115.37 | |
Codexis (CDXS) | 5.3 | $19M | 1.7M | 11.00 | |
Fibrogen (FGEN) | 4.8 | $17M | 360k | 46.20 | |
Strongbridge Bioph shs usd | 4.0 | $14M | 1.6M | 8.85 | |
Corium Intl | 3.5 | $12M | 1.1M | 11.47 | |
Agios Pharmaceuticals (AGIO) | 3.0 | $11M | 130k | 81.78 | |
Fennec Pharmaceuticals (FENC) | 3.0 | $11M | 873k | 12.10 | |
Sangamo Biosciences (SGMO) | 2.9 | $10M | 535k | 19.00 | |
Cymabay Therapeutics | 2.5 | $8.6M | 665k | 12.99 | |
Amag Pharmaceuticals Inc note 2.500% 2/1 | 2.4 | $8.5M | 420k | 20.15 | |
Miragen Therapeutics | 2.1 | $7.4M | 1.1M | 7.01 | |
Deciphera Pharmaceuticals (DCPH) | 2.1 | $7.3M | 365k | 20.04 | |
Ocular Therapeutix | 2.1 | $7.2M | 1.1M | 6.51 | |
Xoma Corp Del (XOMA) | 1.9 | $6.5M | 320k | 20.23 | |
Biofrontera | 1.9 | $6.5M | 391k | 16.52 | |
Ardelyx (ARDX) | 1.6 | $5.7M | 1.1M | 5.05 | |
Audentes Therapeutics | 1.6 | $5.7M | 190k | 30.05 | |
Amarin Corporation (AMRN) | 1.5 | $5.3M | 1.7M | 3.01 | |
Ablynx Nv | 1.4 | $4.9M | 90k | 54.56 | |
Foamix Pharmaceuticals | 1.4 | $4.9M | 950k | 5.13 | |
Viking Therapeutics (VKTX) | 1.4 | $4.8M | 1.1M | 4.37 | |
Ultragenyx Pharmaceutical (RARE) | 1.2 | $4.1M | 80k | 50.99 | |
Achillion Pharmaceuticals | 1.2 | $4.1M | 1.1M | 3.71 | |
DepoMed | 1.1 | $4.0M | 600k | 6.59 | |
Ptc Therapeutics I (PTCT) | 1.1 | $3.9M | 145k | 27.06 | |
Tg Therapeutics (TGTX) | 1.1 | $3.9M | 274k | 14.20 | |
Syndax Pharmaceuticals (SNDX) | 0.9 | $3.2M | 223k | 14.23 | |
Chimerix (CMRX) | 0.9 | $3.1M | 600k | 5.20 | |
Quanterix Ord (QTRX) | 0.7 | $2.6M | 150k | 17.04 | |
Protalix BioTherapeutics | 0.5 | $1.8M | 3.3M | 0.54 | |
Fortress Biotech | 0.4 | $1.4M | 315k | 4.55 | |
Epizyme | 0.4 | $1.2M | 70k | 17.74 | |
Syros Pharmaceuticals | 0.3 | $961k | 74k | 12.97 | |
Zosano Pharma | 0.1 | $504k | 100k | 5.04 | |
Quotient | 0.1 | $282k | 60k | 4.70 | |
Biolinerx Ltd-spons | 0.1 | $215k | 250k | 0.86 |